<DOC>
	<DOC>NCT00560417</DOC>
	<brief_summary>This study will compare insulin lispro protamine suspension (ILPS) and insulin glargine in combination with the patient's oral diabetes medications and exenatide, for their ability to control blood sugar in patients with type 2 diabetes.</brief_summary>
	<brief_title>Comparison of Two Basal Insulins for Patients With Type 2 Diabetes Taking Oral Diabetes Medicines and Exenatide</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus, Type 2</mesh_term>
	<mesh_term>Insulin, Globin Zinc</mesh_term>
	<mesh_term>Exenatide</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Insulin Lispro</mesh_term>
	<mesh_term>Insulin Glargine</mesh_term>
	<mesh_term>Protamines</mesh_term>
	<criteria>Must have type 2 diabetes Must be at least 18 years of age and less than 75 years of age Must be taking exenatide 10 micrograms twice a day (BID) for at least 3 months Must be taking one of the following oral diabetes medication regimens for at least 3 months: (1) metformin (2) metformin + sulfonylurea (3) metformin + thiazolidinedione (TZD). Doses must be at or above the following: Metformin1500 mg/day, Sulfonylurea1/2 the maximum daily dose according to the product label, TZD30 mg/day pioglitazone Must have a hemoglobin A1C greater than or equal to 7.0% and less than or equal to 10.0% Must not have used insulin on a regular basis during the past 2 years Must not have taken any glucoselowering medications not included in the inclusion criteria in the past 3 months Must not have had more than one episode of severe hypoglycemia in the past 6 months Must not have clinically significant hematologic, oncologic, renal, cardiac, hepatic, or gastrointestinal disease Must not be pregnant or intend to get pregnant during the course of the study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>74 Years</maximum_age>
	<verification_date>January 2011</verification_date>
</DOC>